The Use of Doxepin for Urticaria in the Emergency Department

Who is this study for? Patients with Urticaria
Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Isolated urticaria in the emergency department is widely treated by physicians with histamine blocking agents such as diphenhydramine, cetirizine, and cimetidine. Doxepin is a tricyclic antidepressant that has been shown to have much higher concentrations of histamine blocking activity and therefore may be useful in treating urticaria. The purpose of this study is to compare the effectiveness of using doxepin verses a traditional medication, diphenhydramine (Benadryl), in the treatment of isolated urticaria in the emergency department.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Between 18-65 years of age

• Presenting to Upstate Adult Emergency Department at either the Downtown or Community campuses.

• Diagnosed with isolated/acute urticaria

• Requires treatment with antihistamines to alleviate symptoms

Locations
United States
New York
SUNY Upstate Medical University
RECRUITING
Syracuse
Contact Information
Primary
David Andonian, MD
andoniad@upstate.edu
315-464-4363
Time Frame
Start Date: 2022-05-23
Completion Date: 2023-07-01
Participants
Target number of participants: 160
Treatments
Experimental: Doxepin
25mg PO one time
Active_comparator: Diphenhydramine
50mg PO one time
Related Therapeutic Areas
Sponsors
Leads: State University of New York - Upstate Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials